Patents Assigned to Merck Patent GmbH
  • Patent number: 11121323
    Abstract: The present invention relates to a compound of the formula (I), (II) or (III), to the use of the compound in an electronic device, and to an electronic device comprising a compound of the formula (I), (II) or (III). The present invention furthermore relates to a process for the preparation of a compound of the formula (I), (II) or (III) and to a formulation comprising one or more compounds of the formula (I), (II) or (III).
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: September 14, 2021
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Arne Buesing, Christof Pflumm, Teresa Mujica-Fernaud, Philipp Stoessel, Thomas Eberle, Frank Voges
  • Patent number: 11121327
    Abstract: The invention relates to polycondensed lactam compounds as materials for use in electronic devices, and electronic devices, in particular organic electroluminescent devices, containing said materials.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: September 14, 2021
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Christof Pflumm, Thomas Eberle, Anja Jatsch, Elvira Montenegro, Jonas Valentin Kroeber, Rouven Linge
  • Publication number: 20210277006
    Abstract: The present invention refers to a crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and an amino acid ethyl ester like L-phenylalanine ethyl ester or L-methionine ethyl ester, wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid to amino acid ethyl ester is from 1:0.3 to 1:3.0 (in mol/mol) and/or hydrates and/or solvates thereof as well as to a process of obtaining the same.
    Type: Application
    Filed: July 2, 2019
    Publication date: September 9, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Rudolf MOSER, Viola GROEHN, Ruth BOEHNI STAMM, Fritz BLATTER, Martin SZELAGIEWICZ
  • Publication number: 20210277310
    Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, rings A and B, Z1, L1, L2, a and b have the meanings indicated in Claim 1, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PALC, FFS, PS-FFS, IPS or PS-IPS effect.
    Type: Application
    Filed: May 7, 2021
    Publication date: September 9, 2021
    Applicant: Merck Patent GmbH
    Inventors: Melanie KLASEN-MEMMER, Achim GOETZ, Georg BERNATZ
  • Publication number: 20210277309
    Abstract: The present invention relates to a liquid-crystal medium which comprises one or more compounds each of formulae I and II in which the occurring groups and parameters have the meanings given in claim 1.
    Type: Application
    Filed: June 17, 2019
    Publication date: September 9, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Yong-Hyun CHOI, Jae-Hyun KANG, Hyun-Jin YOON
  • Publication number: 20210275533
    Abstract: The present invention refers to a crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester is from 1:0.3 to 1:3.0 (in mol/mol) and/or hydrates and/or solvates thereof as well as to a process of obtaining the same.
    Type: Application
    Filed: July 2, 2019
    Publication date: September 9, 2021
    Applicant: Merck Patent GmbH
    Inventors: Rudolf MOSER, Viola GROEHN, Ruth BOEHNI STAMM, Fritz BLATTER, Martin SZELAGIEWICZ
  • Patent number: 11111226
    Abstract: The present invention relates to novel compounds, particularly to hydrophilic compounds, comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices. The present application also relates to ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: September 7, 2021
    Assignee: Merck Patent GmbH
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Patent number: 11112626
    Abstract: A switchable optical element and method for detecting breakage of a substrate (A, B) of at least one switchable optical element (10) having a first substrate (A) and a second substrate (B), the first substrate (A) being coated with a first electrode and the second substrate (B) being coated with a second electrode, and a switchable layer (14), the switchable layer (14) being sandwiched between the first substrate (A) and second substrate (B), the first electrode and second electrode each having at least one contact, by i) measuring a change in a differential signal measured at two contacts of a substrate (A, B), ii) measuring a change in capacitance between the two substrates (A, B), iii) measuring a change in resistance of at least one of the substrates (A, B), iv) measuring a change in current applied to the switchable optical element (10).
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: September 7, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Ties De Jong, Paul Bakker
  • Patent number: 11115209
    Abstract: The present invention relates to the field of tracing and anti-counterfeit protection of physical objects, and particularly to preparing and performing a secure authentication of such objects. Specifically, the invention is directed to a method and a system for preparing a subsequent secured authentication of a physical object or group of physical objects by a recipient thereof, to a method and system for authenticating a physical object or group of physical objects, to a method and system of securely providing a time-variant combination scheme for authenticating a physical object or group of physical objects according to the above methods, and to related computer programs corresponding to said methods. The invention is based on the concept of increasing the security level by increasing the information entropy of the data on which the anti-counterfeit protection is based by means of random data communicated to authenticating entities in an algorithmically hidden way.
    Type: Grant
    Filed: January 30, 2020
    Date of Patent: September 7, 2021
    Assignee: Merck Patent GmbH
    Inventors: Thomas Endress, Daniel Szabo, Frederic Berkermann, Natali Melgarejo Diaz
  • Publication number: 20210269657
    Abstract: The present invention relates to a composition and to a method of manufacturing a composition.
    Type: Application
    Filed: July 2, 2019
    Publication date: September 2, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Denis GLOZMAN, Ehud SHAVIV, Yuki HIRAYAMA, Teruaki SUZUKI, Christian-Hubertus KUECHENTHAL
  • Publication number: 20210269444
    Abstract: The present invention is directed to a crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid to L-isoleucine ethyl ester is from 1:0.3 to 1:2.0 (in mol/mol) and/or hydrates and/or solvates thereof, as well as, a process of obtaining the same.
    Type: Application
    Filed: July 2, 2019
    Publication date: September 2, 2021
    Applicant: Merck Patent GmbH
    Inventors: Rudolf MOSER, Viola GROEHN, Ruth BOEHNI STAMM, Fritz BLATTER, Martin SZELAGIEWICZ
  • Patent number: 11103512
    Abstract: A crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)-phenyl]-(6-methoxy-pyridazin-3-yl)-methanol can be prepared as a pharmaceutical composition.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: August 31, 2021
    Assignee: Merck Patent GmbH
    Inventors: Michael Lange, Clemens Kuehn, Thomas Fuchss, David Maillard, Marcel Breuning, Marco Poma, Edoardo Burini
  • Patent number: 11104628
    Abstract: The present invention relates to aromatic compounds suitable for preparation of asymmetric polydentate ligands. The present invention further describes a process for preparing asymmetric polydentate ligands and metal complexes comprising these ligands which are suitable for use as emitters in organic electroluminescent devices.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: August 31, 2021
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Christian Ehrenreich
  • Patent number: 11107994
    Abstract: The present invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, comprising these compounds.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: August 31, 2021
    Assignee: Merck Patent GmbH
    Inventors: Dominik Joosten, Anna Hayer, Florian Maier-Flaig, Rouven Linge, Holger Heil
  • Publication number: 20210260060
    Abstract: Methods, compositions, and medical kits are useful for treating and preventing multiple sclerosis using 1-(4-(((6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl)amino)methyl)piperidin-1-yl)prop-2-en-1-one, or a pharmaceutically acceptable salt thereof, according to preferred dosing regimens.
    Type: Application
    Filed: July 19, 2019
    Publication date: August 26, 2021
    Applicant: Merck Patent GmbH
    Inventors: Martin Dyroff, David Mitchell, Orestis Papasouliotis
  • Publication number: 20210260903
    Abstract: The present invention relates to a gravure printing process for the production of a virtual three-dimensional pattern in a coating comprising flake-form effect pigments on a print substrate, to a coating produced in this way, and to the use thereof.
    Type: Application
    Filed: June 17, 2019
    Publication date: August 26, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Johannes TASCH, Ruediger SMOLKA, Peter CLAUTER, Klaus-Christian ULLMANN
  • Publication number: 20210261525
    Abstract: A solid form of 1-(4-{[6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methy}-4-fluoro-piperidin-1-yl)-propenone, or pharmaceutically acceptable salts thereof, is useful as a BTK inhibitor.
    Type: Application
    Filed: June 17, 2019
    Publication date: August 26, 2021
    Applicant: Merck Patent GmbH
    Inventors: Michael LANGE, Clemens Kuehn, Tobias Schlueter, Werner Mederski, David Maillard, Edoardo Burini
  • Publication number: 20210261865
    Abstract: The invention relates to liquid-crystal mixtures which comprise polyfluorinated additives, and to liquid-crystal displays based on these mixtures.
    Type: Application
    Filed: June 4, 2019
    Publication date: August 26, 2021
    Applicant: Merck Patent GmbH
    Inventors: In-Young CHO, Yong-Jun JI, Eun-Kyu LEE, Hye-Ryung PARK
  • Patent number: 11098019
    Abstract: Fluorene derivatives that are connected in one or more of the 1-, 1?-, 4-, or 4?-positions in any combination to a carbon atom of a diaryl substituted triazinyl or pyrimidinyl derivative. The fluorene derivatives are not spirobifluorene derivatives. The compounds are suitable for use in electronic devices, in particular organic electroluminescent devices, comprising these compounds. In some embodiments, the compounds are used as matrix materials for phosphorescent or fluorescent emitters as well as a hole-blocking or an electron-transport layer.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: August 24, 2021
    Assignee: Merck Patent GmbH
    Inventors: Anja Jatsch, Amir Hossain Parham, Thomas Eberle, Tobias Grossmann, Jonas Valentin Kroeber
  • Patent number: 11098050
    Abstract: The present invention relates to organic semiconducting compounds of formula (I) wherein X1 is C, Si or Ge; X2 is 0, S or Se; and X3 is N or P as well as to organic electronic devices comprising such organic semiconducting compounds.
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: August 24, 2021
    Assignee: Merck Patent GmbH
    Inventors: Daniel Becker, Andreas Taugerbeck, Martin Schraub